345 Results (Page 13 of 14)
Singapore Markets Research Reports
Singapore Insulin Market Analysis
This report presents a strategic analysis of the Singapore Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Insulin Market, offering unmatched value, accuracy and expert insights.
Singapore Lung Cancer Drugs Market Analysis
This report presents a strategic analysis of the Singapore Lung Cancer Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Lung Cancer Drugs Market, offering unmatched value, accuracy and expert insights.
Singapore Neurology Drugs Market Analysis
This report presents a strategic analysis of the Singapore Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
Singapore Obesity Drugs Market Analysis
This report presents a strategic analysis of the Singapore Obesity Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Obesity Drugs Market, offering unmatched value, accuracy and expert insights.
Singapore Rheumatology Drugs Market Analysis
This report presents a strategic analysis of the Singapore Rheumatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Rheumatology Drugs Market, offering unmatched value, accuracy and expert insights.
Singapore Skin Antiseptic Products Market Analysis
This report presents a strategic analysis of the Singapore Skin Antiseptic Products Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Skin Antiseptic Products Market, offering unmatched value, accuracy and expert insights.
Singapore Vaccines Market Analysis
This report presents a strategic analysis of the Singapore Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Vaccines Market, offering unmatched value, accuracy and expert insights.
Singapore Women's Health Market Analysis
This report presents a strategic analysis of the Singapore Women's Health Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Women's Health Market, offering unmatched value, accuracy and expert insights.
Singapore Depression Therapeutics Market Analysis
This report presents a strategic analysis of the Singapore Depression Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Depression Therapeutics Market, offering unmatched value, accuracy and expert insights.
Singapore Hospital Market Analysis
The Singapore Hospital Market was valued at $6.60 Bn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $11.46 Bn by 2030. The key drivers of this industry are rise in the geriatric population, shift towards preventive healthcare and medical tourism. The key players in the industry are Mount Elizabeth Hospital, Gleneagles Hospital, Farrer Park Hospital, and Mount Alvernia Hospital among others
Singapore Genomics Market Analysis
The Singapore Genomics market was valued at $39.2 Mn in 2023 and is predicted to grow at a CAGR of 17.10% from 2023 to 2030, to $118.3 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Singapore genomics market are the Genome Institute of Singapore (GIS), NovogeneAIT Genomics, Molecular Genomics, and ACT Genomics, among others.
Singapore Chronic Pain Therapeutics Market Analysis
The Singapore Chronic Pain Therapeutics Market is anticipated to experience a growth from $89 Mn in 2022 to $148 Mn by 2030, with a CAGR of 6.5% during the forecast period of 2022-2030. The key drivers influencing the market growth in Singapore include the aging population leading to a surge in chronic conditions, advancements in medicine fuelling innovative pain management solutions, and increased investment in research and development within Singapore's healthcare hub. The Singapore Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, AbbVie, Sanofi, Merck, Roche, Mylan, Biocon, Cipla, Dr Reddy’s, Sun Pharma, etc., among various others.
Singapore Hemodialysis Equipment Market Analysis
The Singapore Hemodialysis Equipment Market was valued at $16.9 Mn in 2023 and is projected to grow at a CAGR of 8.2% from 2023 to 2023, to $29.4 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Biosensors International, Everlife, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.
Singapore Dental Fluoride Treatment Market Analysis
The Singapore Dental Fluoride Treatment Market was valued at $18.2 Mn in 2023 and is projected to grow at a CAGR of 4.5% from 2023 to 2023, to $24.8 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Pearlie White, Zenyum, Pigeon Singapore, Unilever, P & G among others
Singapore Cold Pain Therapy Market Analysis
The Singapore Cold Pain Therapy Market was valued at $3 Mn in 2022 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $4 Mn by 2030. The key drivers of this industry include an upward trend in the prevalence of chronic pain disorders, rising disposable income, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Ossur, Medline, Pfizer, Hisamitsu, Johnson & Johnson, and Sanofi among others.
Singapore Periodontal Therapeutics Market Analysis
The Singapore Periodontal Therapeutics Market was valued at $1.1 Mn in 2023 and is predicted to grow at a CAGR of 7.8% from 2023 to 2030, to $1.8 Mn by 2030. Singapore Periodontal Therapeutics Market is growing due to Aging population, Rise in Demand for Non-surgical Periodontal Therapies, and Prevalence of periodontitis. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Singapore Radiology Service Market Analysis
The Singapore Radiology Service Market was valued at $4.8 Mn in 2023 and is predicted to grow at a CAGR of 15.3% from 2023 to 2030, to $13 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Singapore Radiology Service Market are Mount Elizabeth Hospital, National University Hospital (NUH)-Singapore, Gleneagles Hospital, Mount Elizabeth Novena Hospital, Parkway East Hospital, Mount Alvernia Hospital, among others.
Singapore Hemodialysis Vascular Grafts Market Analysis
Singapore Hemodialysis Vascular Grafts Market was valued at $250 Mn in 2023 and is predicted to grow at a CAGR of 5.7% from 2023 to 2030, to $370 Mn by 2030. The key drivers of this industry include the rising prevalence of end-stage renal disease, high healthcare expenditure, and focus on quality care. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
Singapore Chronic Cough Therapeutics Market Analysis
Singapore Chronic Cough Therapeutics Market was valued at $8 Mn in 2022 and is estimated to reach $15 Mn in 2030, exhibiting a CAGR of 8.7% during the forecast period. The predominant factor driving the growth of the chronic cough therapeutics market is the prevalent occurrence of persistent coughing associated with chronic respiratory infections. Leading entities in this sector currently include Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Hikma Pharmaceuticals, and Abbott Laboratories.
Singapore MRI Market Analysis
The Singapore MRI Market was valued at $7.97 Mn in 2023 and is predicted to grow at a CAGR of 7.1% from 2023 to 2030, to $12.88 Mn by 2030. The key drivers of this industry include the rise in geriatric population, increasing demand for advanced imaging technologies, and expanding healthcare spending. The key players in the industry are GE Healthcare, Koninklijke Philips NV, Mindray Medical International, and Bruker among others.
Singapore Conjunctivitis Therapeutics Market Analysis
The Singapore Conjunctivitis Therapeutics Market was valued at $5 Mn in 2022 and is predicted to grow at a CAGR of 6% from 2023 to 2030, to $8 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, new therapeutics development in the industry, and supportive government initiatives. The industry is primarily dominated by players such as Allergan, Bausch & Lomb, Novartis, Rohto, Santen, Sirion, and Alembic among others.
Singapore PET Scan Market Analysis
The Singapore PET Scan Market was valued at $2.3 Mn in 2023 and is predicted to grow at a CAGR of 6% from 2023 to 2030, to $3.5 Mn by 2030. The key drivers of the market include increased healthcare expenditure, increased geriatric population, and rising prevalence of chronic diseases. The prominent players of the Singapore PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, and Hitachi, among others.
Singapore Genomic Diagnostics Market Analysis
Singapore Genomic Diagnostics Market was valued at $39.18 Mn in 2023 and is predicted to grow at a CAGR of 17.1% from 2023 to 2030, to $118.29 Mn by 2030. The key drivers of this industry include government support and infrastructure, rising demand for personalized medicine, and medical tourism. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Singapore Bio-implant Market Analysis
The Singapore Bio-implant Market was valued at $78 Mn in 2023 and is predicted to grow at a CAGR of 6.5% from 2023 to 2030, to $121.2 Mn by 2030. The Singapore Bio-implant Market is growing due to like Medical Tourism, Healthcare Infrastructure, Government Support. The market is primarily dominated by players such as Invivo Medical, Veredus Laboratories, Biosensors International Group, Ltd. Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc.
Singapore Compression Therapy Market Analysis
Singapore Compression Therapy Market was valued at $5 Mn in 2022 and is estimated to reach $7 Mn in 2030, exhibiting a CAGR of 6.2% during the forecast period. The growing prevalence of venous conditions like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a significant driver for the growth of the compression therapy market. Key players in this industry comprise firms such as Mölnlycke Health Care, Sigvaris, Medi GmbH & Co., Bauerfeind, BSN Medical, Hartmann Group, GC Medical Supply Co., Juzo, McKesson, and Cardinal Health.